QA: Kura Oncology Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001422143_2018_Kura_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001422143, Kura Oncology Inc

  xvar xval
0 AssetsCurrent 94,641,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,000
3 remainder_Assets 1,200,000
4 LiabilitiesCurrent 10,031,000
5 LiabilitiesNoncurrent 5,955,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 38,524,209
11 remainder_Revenues 0
12 remainder_NetIncome 677,599
13 remainder_ComprehensiveNetIncome 47,285
  yvar yval
0 Assets 95,851,000
1 Liabilities 15,986,000
2 Expenses 38,524,209
3 Revenues 0
4 StockholdersEquity 79,865,000
5 NetIncome -37,846,610
6 ComprehensiveNetIncome -37,822,968
7 BaseVar 75,543,046
8 EconomicCapitalRatiobeforeLimitedLiability 2.44
9 EconomicCapitalRatio 3.31

Edgar->Model Mapping

Feature Distribution

Change over Time